Results GI symptoms occur in approximately 1 in 6 patients with amyloidosis, but symptoms correlate poorly with gastrointestinal deposition
Our GLP-1 medical weight loss program uses prescription medication to address appetite and blood sugar appropriate for clients with more significant goals
Two small RCTs found greater efficacy from phenobarbital as compared to valproic acid for the treatment of benzodiazepine-refractory status epilepticus
Learn More About BPC-157 Looking for more information about BPC-157 therapy, pricing, benefits, and provider-guided care
For example, people with digestive issues may not absorb liquid, gummy, or pill forms of vitamin B12 effectively
Prog Neuropsychopharmacol Biol Psychiatry (2011) 35:74459